Ocimum sanctum for COVID-19

Ocimum sanctum may be beneficial for COVID-19 according to the studies below. COVID-19 involves the interplay of 500+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 12,000+ potential treatments. c19early.org analyzes 220+ treatments. We have not reviewed Ocimum sanctum in detail.
Amtaghri et al., Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review, Journal of Pharmacy and Pharmacology, doi:10.1093/jpp/rgae101
Abstract Aims The aim of the present review was to highlight natural product investigations in silico and in vitro to find plants and chemicals that inhibit or stimulate angiotensin-converting enzyme 2 (ACE-2). Background The global reduction of incidents and fatalities attributable to infections with SARS-CoV-2 is one of the most public health problems. In the absence of specific therapy for coronavirus disease 2019 (COVID-19), phytocompounds generated from plant extracts may be a promising strategy worth further investigation, motivating researchers to evaluate the safety and anti-SARS-CoV-2 effectiveness of these ingredients. Objective To review phytochemicals in silico for anti-SARS-CoV-2 activity and to assess their safety and effectiveness in vitro and in vivo. Methods The present review was conducted using various scientific databases and studies on anti-SARS-CoV-2 phytochemicals were analyzed and summarized. The results obtained from the in silico screening were subjected to extraction, isolation, and purification. The in vitro studies on anti-SarcoV-2 were also included in this review. In addition, the results of this research were interpreted, analyzed, and documented on the basis of the bibliographic information obtained. Results This review discusses recent research on using natural remedies to cure or prevent COVID-19 infection. The literature analysis shows that the various herbal preparations (extracts) and purified compounds can block the replication or entrance of the virus directly to carry out their anti-SARS-CoV-2 effects. It is interesting to note that certain items can prevent SARS-CoV-2 from infecting human cells by blocking the ACE-2 receptor or the serine protease TMPRRS2. Moreover, natural substances have been demonstrated to block proteins involved in the SARS-CoV-2 life cycle, such as papain- or chymotrypsin-like proteases. Conclusion The natural products may have the potential for use singly or in combination as alternative drugs to treat/prevent COVID-19 infection, including blocking or stimulating ACE-2. In addition, their structures may provide indications for the development of anti-SARS-CoV-2 drugs.
Dilip Bhandare, S., Exploration of medicinal plants as potential therapeutics against COVID-19: molecular insights and drug development prospects with other significant medicinal information a retrospective exposition, Journal of Pharmacy and Pharmacology, doi:10.1093/jpp/rgae074
Abstract Objectives The study aims to explore the potential of medicinal plants and their phytoconstituents as effective inhibitors of the coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus. The focus is on investigating specific medicinal plants known for their pharmacological properties, such as: antioxidant, anti-inflammatory, and immunomodulatory effects, to determine their viability in developing COVID-19 treatments. Materials and methods This study involves a comprehensive study of medicinal plants, including: Withania somnifera (Ashwagandha) and Ocimum sanctum (Holy Basil), known for their beneficial health effects. Molecular docking studies were conducted to assess the interactions between phytoconstituents from these plants and SARS-CoV-2 proteins. The compounds’ drug-like characteristics and safety profiles were also evaluated to determine their potential as therapeutic agents. Results The molecular docking studies revealed that the phytoconstituents from the studied medicinal plants exhibit favourable interactions with SARS-CoV-2 proteins, suggesting their potential as therapeutic targets. These compounds demonstrated promising drug-like characteristics and safety profiles, indicating their suitability for further development as COVID-19-fighting medications. Discussion The results indicate that medicinal plants and their bioactive substances hold significant potential for developing therapies against COVID-19. The ability of these organic substances to interact with key viral proteins and provide various therapeutic benefits highlights their potential as multi-functional treatment options. However, further research is necessary to confirm these findings and to understand the full scope of their therapeutic efficacy and safety in clinical settings. Conclusions Medicinal plants and their phyto-constituents represent a promising avenue for developing effective treatments for COVID-19. The favourable interactions with SARS-CoV-2 proteins and the promising drug-like characteristics observed in this study suggest that these natural compounds could be integral in the fight against the COVID-19 pandemic. Further research and clinical trials are essential to fully validating their potential and translating these findings into practical medical applications.
Khaledi et al., A Comprehensive Review of Herbal Recommendations with the Potential to Inhibit COVID-19 Infection, Journal of Medical Bacteriology, doi:10.18502/jmb.v11i5-6.14362
Background: The outbreak of Coronavirus Disease 2019 (COVID-19) has originated from Wuhan, China and rapidly spread all over the world. This disease is caused by a coronavirus termed Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) that mainly infects the human respiratory tract. Herbal agents including Atractylodes lancea, Ephedra, Curcumin, and Echinacea purpurea had immunomodulatory effects and antiviral activities on other respiratory viruses including Influenza virus. They strengthen the innate immunity through increasing the phagocytic activity and antiinflammatory activity. These herbs could be used as a complementary therapy to prevent entry of COVID-19 and improve immune system. This review delves into the role and therapeutic compounds of various herbal agents in relation to immunity, their effectiveness in treating other viral respiratory illnesses, and their potential influence on COVID-19 disease.
Yahaya et al., A Review of Anti-coronavirus Medicinal Plants, Fruits, and Vegetables, Journal of Research in Complementary Medicine, doi:10.5455/JRCM.20240602064235
There is currently no particular cure for coronavirus disease-19 (COVID-19). However, studies suggest that certain medicinal plants, fruits, and vegetables possess bioactive substances capable of ameliorating the disease. This review aims to articulate fruits, vegetables, and medicinal plants that have anti-coronavirus properties. Relevant articles were collected from reputable academic repositories, namely SpringerLink, PubMed, Google Scholar, and Scopus. Available information shows that alkaline-rich fruits and vegetables, such as mango, cabbage, lemon, onion, okra, carrot, cucumber, pepper, spinach, and avocado, have anti-coronavirus properties. The mentioned fruits and vegetables stimulate an unfavorable pH for the replication of the virus and normalize the acid-base imbalance induced in the lungs and kidneys of the infected. Fruits and vegetables also contain health-boosting substances such as proteins, amino acids, glycosides, vitamins, and minerals. Medicinal plants, including Clitoria ternatea L., Vitex trifolia L., Sphaeranthus indicus L., Clerodendrum inerme L. Gaertn., Glycyrrhiza glabra L., Strobilanthes cusia (Nees) Kuntze, Vitis vinifera var. aestivalis (Michx.) Kuntze, Hyoscyamus niger L., and Cedrela Sinensis Juss., also possess anti-coronavirus properties. Clitoria ternatea and Cedrela sinensis reduce the virus’s replication by shredding its receptor, called the angiotensin-converting enzyme 2 (ACE2). Vitex trifolia and Sphaeranthus indicus prevent hyper-inflammatory responses and cytokine storms. Glycyrrhiza glabra induces nitrous oxide synthase and blocks the virus’s replication. Clerodendrum inerme and Strobilanthes cusia inhibit the virus’s ribosome and protein translation. Vitis vinifera represses nucleocapsid protein and lowers apoptosis. Hyoscyamus niger inhibits Ca2+ channels and lessens breathing difficulties induced by the coronavirus. Thus, dietary supplements and drugs formulated with these medicinal plants, fruits, and vegetables may lessen the effects of COVID-19.